Your browser doesn't support javascript.
loading
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma.
Jiang, Han-Yu; Zheng, Hui-Min; Xia, Cheng; Li, Xiang; Wang, Gang; Zhao, Tong; Cui, Xiao-Nan; Wang, Ruo-Yu; Liu, Ying.
Afiliação
  • Jiang HY; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Zheng HM; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Xia C; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Li X; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Wang G; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Zhao T; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Cui XN; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China.
  • Wang RY; Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
  • Liu Y; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Dalian, People's Republic of China.
Onco Targets Ther ; 15: 291-298, 2022.
Article em En | MEDLINE | ID: mdl-35345394

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2022 Tipo de documento: Article